Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06432868 · ClinicalTrials.gov registry record · NA
Solarplast (R) Supplementation Effects Following High-intensity Resistance Exercise
A NA study of Muscle Damage, sponsored by Kent State University.
- Recruiting
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT06432868 is a NA study of Muscle Damage that is actively recruiting participants, run by Kent State University. The registered enrollment target is 46 participants, above the 37-participant average among 6 other Muscle Damage trials with a reported enrollment target (24% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06432868, a NA study of Muscle Damage, is actively recruiting participants, sponsored by Kent State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary goal of this investigation is to assess whether Solarplast (R) supplementation will improve recovery following heavy resistance exercise in active adults. The primary questions to be addressed are: Does Solarplast (R) decrease muscle damage and inflammation associated with heavy resistance exercise? Does Solarplast (R) reduce the decline in performance associate with heavy resistance exercise? Researchers will compare Solarplast (R) to a placebo (a look-alike substance that contains no active ingredients) to see if Solarplast (R) is effective at improving recovery. Participants will be asked to: Take Solarplast (R) or placebo daily for 4 weeks Visit the laboratory at least once per week to receive their supplement Report to the lab for 3 consecutive visits following supplementation to complete a heavy resistance training session and follow-up testing.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Solarplast (R)
Study Locations (1)
Ohio
- Kent State University - Exercise Science & Exercise Physiology - Kent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2024-04-17 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06432868
The ClinicalTrials.gov registry entry for NCT06432868 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 37-participant average among 6 other Muscle Damage trials with a reported enrollment target (24% higher). The listed sponsor is Kent State University, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Muscle Damage appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06432868 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06432868 about?
NCT06432868 is a clinical study titled "Solarplast (R) Supplementation Effects Following High-intensity Resistance Exercise". The primary goal of this investigation is to assess whether Solarplast (R) supplementation will improve recovery following heavy resistance exercise in active adults. The primary questions to be addressed are: Does Solarplast (R) decrease muscle damage and inflammation associated with heavy resista...
What is the current status of trial NCT06432868?
This trial is currently recruiting. It is a NA study. The enrollment target is 46 participants. The study started on 2024-04-17. Estimated completion is 2025-03-31.
What conditions does trial NCT06432868 study?
This clinical trial studies the following conditions: Muscle Damage.
What interventions are being tested in trial NCT06432868?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Solarplast (R) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06432868?
This trial is sponsored by Kent State University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06432868 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Muscle Damage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Vicia Faba Hydrolysate Supplementation on Muscle Strength Recovery
RECRUITING · NA
-
Comparing Two Eccentric Protocols on Muscle Damage
RECRUITING · NA
-
HIFEM and Radiofrequency for Muscular System Function Improvement
ACTIVE NOT RECRUITING · NA
-
Protein and Recovery From Exercise-induced Muscle Damage
COMPLETED · NA
-
Comparison of Pre-exercise Beta-hydroxy-beta-methylbutyrate Free Acid (HMB-FA) and Cold Water Therapy for the Attenuation of Muscle Damage and Soreness
COMPLETED · NA
-
The Long-term Effects of Oceanix™ on Resistance Training Adaptations
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.